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1  | INTRODUC TION
Aging populations have led to an increasing number of end stage 
renal disease (ESRD) patients on maintenance hemodialysis (HD).1 
Current studies suggest arteriovenous fistula (AVF) as the preferred 
vascular access (VA) type for elderly HD patients due to longer pa-
tency and lower incidence of VA-related infection.2,3
It has been widely acknowledged that ventricular remodeling and 
dysfunction, assessed by echocardiography, develop following AVF 
creation and dialysis initiation. Furthermore, the risk of pulmonary hy-
pertension (PAH) due to high-flow rate of AVF was increased despite 
improved left ventricular (LV) pressure and volume load through dial-
ysis.4-6 This, raised the issue that what kind of cardiac structure and 
function patients had at baseline, could tolerate the adverse effects 
derived from AVF and provide the AVF with adequate blood flow for 
HD treatment. To date, few studies have identified the association 
between preoperative echocardiography and the outcomes of AVF.
Although preoperative retention of temporary catheter was 
thought to be correlated with lower patency of AVF,3,7 it remains 
unclear whether the previous modality and location of VA also 
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Abstract
The objective of this study was to examine the impact of cardiac structure and function 
at baseline on the outcomes associated with arteriovenous fistula (AVF) in patients on 
hemodialysis (HD). Patients who initiated HD aged ≥70 years and received a mature AVF 
creation were included retrospectively. Echocardiographic parameters measured within 
1 week before AVF creation were acquired. The observational period for each patient 
was from the point of AVF creation to the last time of follow-up unless AVF abandon-
ment or death occurred. Kaplan-Meier and Cox proportional hazard regression analyses 
were conducted. A total of 82 elderly Chinese HD patients with mature radiocephalic 
AVF (RCAVF) and EF ≥50% were analyzed. During the median study period of 26.8 (12-
40) months, 42 (51.2%) experienced RCAVF dysfunction and 34 (41.5%) progressed to 
abandonment. Primary and cumulative patencies at 6, 12, 24, and 36 months were 81%, 
73%, 48%, 38%, and 84%, 81%, 68%, 55%, respectively. Left ventricle end-diastolic vol-
ume (LVEDV) ≤103.5 mL (HR = 2.5, P = .019) and the right side of RCAVF (HR = 3.59, 
P = .003) significantly predicted RCAVF dysfunction. The main pulmonary artery internal 
diameter (MPAID) ≤21.5 mm (HR = 4.3, P = .001) as well as the right side (HR = 2.95, 
P = .047) were the independent predictors for RCAVF abandonment. In conclusion, 
LVEDV, MPAID assessed by echocardiography and the right side of RCAVF, showed sig-
nificant predictive implications for the outcomes of RCAVF. Disparities among nationali-
ties in the areas of utilization and patency of AVFs necessitate additional studies.
DOI: 10.1111/sdi.12871  
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contribute to the outcomes of AVF. In addition, different regions 
have varied requirements on dialysis flow, which could result in a 
potential discrepancy in functional life of AVFs.8,9 Related data for 
elderly Chinese ESRD patients have been scarce.
Based on the above, we designed a retrospective study and 
aimed to: (a) explore the prognostic value of echocardiographic in-
dexes and prior VA history for the outcomes of AVF; and (b) report 
the utilization and patency of AVFs for elderly HD patients in China.
2  | MATERIAL S AND METHODS
2.1 | Study population
We retrospectively reviewed ESRD patients aged ≥70 years who 
were admitted to our hospital and obtained a mature AVF creation.
Patients were excluded when: (a) they initiated HD before the 
age of 70; (b) their ejection fraction (EF) <50% or echocardiographic 
parameters were incomplete before AVF creation; (c) they under-
went HD combined with, or switched to, peritoneal dialysis; (d) they 
died from any cause during the hospitalization of AVF creation; (e) 
the dialysis remained dependent on other VAs for an unmatured 
AVF; (f) they had not initiated HD yet or withdrew from HD due to 
stable renal function based on maintenance medication until last fol-
low-up, even if the AVFs achieved maturation; (g) they were lost to 
contact, or they refused to be investigated.
2.2 | Clinical data collection and definitions
Clinical data were collected through electronic medical records, in-
cluding demographic characteristics, etiology of ESRD, coexisting 
conditions, echocardiographic parameters within 1 week prior to 
AVF creation, preoperative HD status, and the location of AVF.
For each patient, the patency, dysfunction, intervention, and 
abandonment of the AVF were acquired by reviewing the patient's 
readmission records and initiating phone calls to patients’ homes. 
The last follow-up was defined as the point of last contact at a dial-
ysis center, outpatient clinic, inpatient ward or through phone call. 
The study period for each patient was from the point of AVF cre-
ation to the last time of follow-up unless AVF abandonment or death 
occurred. Maturation,8 primary and cumulative patency, AVF aban-
donment10 were defined in accordance with published standards. In 
addition, serum biochemical indices were excluded from the analy-
sis, because the concentration of serum biomarkers on entry may 
not represent the actual level as some patients underwent HD or 
blood transfusion treatment before admission to our clinic.
2.3 | Statistical analysis
Patients were assigned to groups according to the dysfunction 
or abandonment of AVF during the study period. The continuous 
variables are presented as mean (standard deviation), or median 
(interquartile range) when the values did not show a normal dis-
tribution. Categorical variables are presented as percentages. 
The Kruskal-Wallis H test was used for continuous variables, 
while the chi-square test was applied to assess the categorical 
data.
Receiver operating characteristic (ROC) curves were gener-
ated to determine the optimal cut-off value. Kaplan-Meier curves 
were utilized to demonstrate differences in survival. Log rank 
tests were performed to examine the significance of the differ-
ence between the curves. Variables with P < .05 in the univariate 
analysis and those considered clinically important were entered 
into Cox proportional hazards regression models to explore pre-
dictors for outcomes of AVF. A value of P < .05 was regarded as an 
acceptable threshold for significance. Data were analyzed using 
SPSS version 22.0.
3  | RESULTS
3.1 | Inclusion of subjects and follow-up procedure
One hundred and eighty HD patients aged ≥70 years with a total of 
220 AVF surgeries at our hospital from January 2007 to October 
2018 were screened through electronic medical records by two 
investigators. Among these surgeries, 143 AVFs achieved matura-
tion, 66 AVFs failed to mature, and the remaining 11 failed immedi-
ately (no murmur or tremor was detected within 72 hours after AVF 
creation).
The final follow-up dates were observed between January 2019 
and March 2019. After excluding 98 patients, 82 eligible participants 
with a median follow-up period of 26.8 (12-40) months were in-
cluded in the final analysis. All of them received radiocephalic AVFs 
(RCAVFs).
3.2 | Characteristics at baseline and 
outcomes of RCAVFs
Among the 82 elderly HD patients, 42 (51.2%) experienced RCAVF 
dysfunction and 34 (41.5%) progressed to abandonment. The base-
line clinical, echocardiographic, and previous VA and RCAVF charac-
teristics of the subjects were summarized in Tables 1 and 2. There 
was no history of peripheral vascular disease (PVD) or arteriovenous 
graft in this cohort.
In terms of patency for the mature RCAVFs, primary and cu-
mulative patencies at 6, 12, 24, and 36 months were 81%, 73%, 
48%, 38%, and 84%, 81%, 68%, 55%, respectively. As for the cause 
of RCAVF dysfunction, 38 (90.5%) patients had AVF stenosis, 4 
(9.5%) suffered from venous hypertension syndrome or central 
venous stenosis. In regard to intervention, 13 cases of balloon an-
gioplasty, 1 case of balloon angioplasty + stent deployment, and 8 
cases of surgical revision were performed for 15 patients.
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TA B L E  1   Characteristics in groups according to RCAVF abandonment
Characteristic Total Abandoned No abandoned Pa 
No. of patients 82 34 48 —
Age (year) 73 (71-75) 74 (71-76) 73 (71-75) 0.29
Male no. (%) 49 (59.8) 16 (47.1) 33 (68.8) 0.048
Etiology of ESRD no. (%)    0.61
Diabetic nephropathy 27 (32.9) 13 (38.2) 14 (29.2) —
Hypertensive nephropathy 37 (45.1) 15 (44.1) 22 (45.8) —
Others 18 (22) 6 (17.7) 12 (25) —
Previous medical history no. (%)     
Diabetes mellitus 40 (48.8) 14 (41.2) 26 (54.2) 0.25
Congestive heart failure 5 (6.1) 2 (5.9) 3 (6.3) 0.95
Coronary heart disease 3 (3.7) 2 (5.9) 1 (2.1) 0.37
Preoperative assessment
Systolic blood pressure (mm Hg) 146 (130-155) 149 (122-155) 146 (133-156) 0.70
Diastolic blood pressure (mm Hg) 75.9 (11.2) 74.7 (7.7) 76.8 (13.2) 0.01
Ejection fraction (%) 66.1 (5.5) 66.7 (5.9) 65.7 (5.3) 0.37
LAID (mm) 38.7 (5.2) 38.5 (5.9) 38.8 (4.6) 0.18
RAID (mm) 36 (33-39) 35 (33-38) 37 (34-39) 0.28
LVID (mm) 48 (46-52) 47 (45-49) 49 (46-54) 0.012
RVID (mm) 21 (20-23) 20 (20-22) 22 (20-23) 0.05
AAOID (mm) 34.3 (3.4) 34 (3.7) 34.4 (3.2) 0.47
MPAID (mm) 22 (21-24) 21 (20-23) 23 (21-26) 0.001
LVESV (mL) 34.5 (29-44) 30 (27-40) 36.5 (32-48) 0.004
LVEDV (mL) 107 (94-127) 100 (91-112) 111 (98-139) 0.009
LVSV (mL) 70 (62-86) 67 (61-80) 75 (64-93.5) 0.022
Previous vascular access history
No. of PVAb  0 (0-3) 0 (0-2) 0 (0-3) 0.91
Functional length of tcCVCsb  (mo) 0 (0-72) 0 (0-17) 0 (0-72) 0.56
Functional length of AVFsb  (mo) 0 (0-1) 0 (0-1) 0 (0-1) 0.94
Immediate AVFs failure no. (%) 4 (4.9) 3 (8.8) 1 (2.1) 0.16
AVF maturation failure no. (%) 6 (7.3) 4 (11.8) 2 (4.2) 0.19
Duration of FV-ntCVCs (mo) 0 (0-2) 0.75 (0-2.5) 0 (0-0.7) 0.036
Duration of IJV-ntCVCs (mo) 0 (0-2) 0 (0-0) 0 (0-2.2) 0.025
Length of previous dialysis (mo) 0.2 (0-0.7) 0.1 (0-0.5) 0.2 (0-0.7) 0.45
Outcomes of current RCAVF
Right RCAVF no. (%) 19 (23.2) 11 (32.4) 8 (16.7) 0.1
Maturation period (mo) 2.5 (2-3) 2.5 (2-3) 2.5 (2-3) 0.79
Primary patency (mo) 23.8 (11-31) 14.5 (8-27) 26.5 (14.5-38.5) 0.002
No. of interventionsb  0 (0-4) 0 (0-4) 0 (0-3) 0.27
Length of follow-up (mo) 26.8 (12-40) 19.5 (9-39) 27.5 (21.8-41.8) 0.045
Abbreviations: AAOID, ascending aorta internal diameter; FV, femoral vein; IJV, internal jugular vein; LAID, left atrium internal diameter; left 
ventricle stroke volume; LVEDV, left ventricle end-diastolic volume; LVESV, left ventricle end-systolic volume; LVID, left ventricle internal diameter; 
LVSV;MPAID, main pulmonary artery internal diameter; ntCVC, nontunneled central venous catheter; PVA, permanent vascular access; RAID, right 
atrium internal diameter; RCAVF, radiocephalic arteriovenous fistula; RVID, right ventricle internal diameter; tcCVC, tunneled cuffed central venous 
catheter.
aP value for comparison among two groups excluding the total group. 
bVariables are presented as median (full range) since their median (interquartile range) are both 0 (0-0). 
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3.3 | Predictors for outcomes of RCAVF in Cox 
hazard regression analysis
According to the results of univariate (Table 1, 2) and ROC (data 
not listed) analyses, LV internal diameter (LVID), main pulmonary ar-
tery internal diameter (MPAID), LV end-systolic volume (LVESV), LV 
end-diastolic volume (LVEDV), and LV stroke volume (LVSV) showed 
significant differences between groups. Because of the correlation 
among the three values (LVSV = LVEDV-LVESV), only LVID, MPAID, 
and LVEDV were selected to be included in the regression models.
As presented in Table 3, LVEDV ≤103.5 mm Hg and the right side 
of operations were independent predictors for RCAVF dysfunction. 
Moreover, the survival curve of RCAVFs with LVEDV >103.5 mm 
(Figure 1) indicated longer survival times compared to those with 
LVEDV ≤103.5 (P = .005).
For RCAVF abandonment, MPAID (whether presented as a con-
tinuous or categorical variable according to the optimal cut-off value 
of ≤21.5 mm), and the right side acted as significant predictors in the 
two Cox regression analyses (Table 4 model a and b). Furthermore, 
the survival of RCAVFs in the group with MPAID >21.5 mm (Figure 2) 
showed better outcomes than the converse group.
4  | DISCUSSION
4.1 | Echocardiography and surgical site in 
predicting outcomes of RCAVF
In the present study on 82 Chinese ESRD patients who initiated HD 
aged ≥70 years, the factors involving previous VAs, reflected not 
only the dialysis vintage but also a potential proneness to vascular 
intimal hyperplasia (IH) and thrombosis. These factors were ad-
justed when we explored the predictors for RCAVF dysfunction and 
abandonment.
In the cohort with normal cardiac systolic function (EF ≥50%), 
LVEDV and the right side of RCAVF were independent predictors 
Characteristica  Total Unusable Usable Pb 
No. of patients 82 42 40 —
Age (year) 73 (71-75) 74 (71-76) 72.5 (71-75) .44




146 (130-155) 146.5 (124-155) 146 (134-157) .45
Diastolic blood 
pressure (mm Hg)
75.9 (11.2) 74.8 (9.4) 77.1 (12.9) .024
LVID (mm) 48 (46-52) 47 (45-49) 50 (47-54) .006
LVESV (mL) 34.5 (29-44) 30 (28-41) 36 (32-51) .01
LVEDV (mL) 107 (94-127) 100 (91-112) 112 (99-141) .009
LVSV (mL) 70 (62-86) 67 (61-81) 76 (67-94) .011
Previous vascular access history
No. of PVAc  0 (0-3) 0 (0-2) 0 (0-3) .38
Functional length of 
tcCVCsc  (mo)
0 (0-72) 0 (0-17) 0 (0-72) .17
Functional length of 
AVFsc  (mo)
0 (0-84) 0 (0-84) 0 (0-51) .76
Duration of FV-
ntCVCs (mo)
0 (0-2) 0.28 (0-2.3) 0 (0-0.6) .06
Duration of IJV-
ntCVCs (mo)
0 (0-2) 0 (0-1) 0 (0-2.2) .16
Right RCAVF (%) 19 (23.2) 14 (33.3) 5 (12.5) .025
Length of follow-up 
(mo)
23.8 (11-31) 16.5 (8-28) 26 (14.5-39.5) .007
Abbreviations: FV, femoral vein; IJV, internal jugular vein; left ventricle stroke volume; LVEDV, 
left ventricle end-diastolic volume; LVESV, left ventricle end-systolic volume; LVID, left ventricle 
internal diameter; LVSV, left ventricle stroke volume;ntCVC, nontunneled central venous catheter; 
PVA, permanent vascular access; RCAVF, radiocephalic arteriovenous fistula; tcCVC, tunneled 
cuffed central venous catheter.
aVariables with P < .05 in the comparison or those considered clinically important are listed. 
bP value for comparison among two groups excluding the total group. 
cVariables are presented as median (full range) since their median (interquartile range) are both 0 (0-0). 
TA B L E  2   Characteristics in groups 
according to RCAVF dysfunction
     |  313XIONG et al.
for dysfunction. Patients with LVEDV ≤103.5 mL possessed 2.5 
times increased risk compared to those with LVEDV >103.5 mL 
(Table 3). This might indicate an insufficient cardiac diastolic 
function for the gradually increased blood volume flowing back 
to the heart after RCAVF creation, which in turn intensified 
the pressure of AVF outflow tract and restricted its flow. The 
sustaining pressure could induce IH or stenosis of the whole 
HD access circuit, thereby promoting the development of AVF 
dysfunction.
Our clinic typically chose nondominant upper extremity (mostly 
left arm in this cohort) as the surgical site in keeping with guide-
lines,8 the exceptional employments of right arm in 19 patients 
implied their poor overall vascular conditions. Besides, previous 
placements of right internal jugular vein catheter were prone to 
causing proximal traumatic stenosis of the ipsilateral AVF circuit, 
which might impair the function of right RCAVF. Therefore, it makes 
sense that the risk for RCAVF dysfunction and abandonment on 
the right side showed over three times greater risk than the left 
(Tables 3 and 4).
In addition to surgical site, MPAID acted as a strong predictor 
for RCAVF abandonment in the population without PAH at baseline. 
MPAID ≤21.5 mm before AVF creation had over fourfold the risk for 
AVF abandonment as those whose MPAID was larger, with the risk 
decreasing by 32% per each 1 mm elevation (Table 4). As a structural 
indicator of the heart, smaller MPAID might suggested an irrevers-
ible low tolerance to the increasing blood flow that returned to the 
heart. Since the occlusion of AVF could reverse the deterioration 
of cardiac function,11 and most of abandoned AVFs in this cohort 
converted to other types of VA in further observation,12 prognostic 
analysis of echocardiographic parameters or AVF on cardiovascular 
outcome was not conducted in this study.
4.2 | Patencies and outcomes of RCAVF in Chinese 
ESRD patients aged ≥70 years
A maturation rate of 68.4% was calculated in the 209 AVFs. RCAVF 
was the more common choice for the aged in our clinic compared 
to brachiocephalic AVF (BCAVF). This was mainly due to concerns 
about the greater possibility that high-flow AVF formation increased 
the risk for high-output cardiac failure.11,13-15 Even though BCAVF 
was reported with higher patency,16 several centers published excel-
lent results for RCAVFs in the elderly.17
Patients in the study demonstrated superior primary patencies 
compared to their counterparts aged ≥70-75 years (54% at 12 months 
for British, 73.1% at 6 months and 57.1% at 12 months for Koreans; 
39.7% at 12 months and 31.2% at 24 months for Americans), and 
also better cumulative patencies (66% at 12 months for British; 56% 
at 12 months and 51% at 24 months for Americans).2,18,19 Observed 
values were much closer to a general Chinese ESRD population,7 con-
firming the regional differences. Our Chinese cohort had longer mat-
uration time and greater patency compared with the United States 
or Europe,8,9 which was consistent with previous studies showing an 
inverse correlation between maturation time and AVF failure.20,21 
Also, the lower routine blood flow (200-300mL/min) during HD 
treatment in China, might preserve the function and lifetime of AVF. 
Another reason that might contribute to these differences was that 
TA B L E  3   Cox proportional hazard regression models for RCAVF 
dysfunction
Variable (per 1 unit increased) or 
(yes vs no) HR 95%CI P
Male 1.2 0.58-2.47 .63
Age (year) 1.06 0.96-1.17 .23
Diabetes mellitus 0.81 0.41-1.58 .53
DBP (mm Hg) 0.97 0.94-1 .08
LVID (mm) ≤48.5 1.8 0.76-4.24 .18
LVEDV (mL) ≤103.5 2.5 1.17-5.37 .019
Previous No. of PVA 0.63 0.22-1.76 .38
Previous functional length of AVFs 
(mo)
1.01 0.98-1.05 .5
Previous functional length of 
tcCVCs (mo)
1 0.89-1.12 .99
Previous duration of FV-ntCVC (mo) 1.14 0.92-1.41 .25
Previous duration of IVJ-ntCVC (mo) 0.92 0.75-1.13 .42
Right RCAVF 3.59 1.54-8.39 .003
Abbreviations: DBP, diastolic blood pressure; FV, femoral vein; 
HR, Hazard rate; CI, confidence interval; IJV, internal jugular vein; 
LVEDV, left ventricle end-diastolic volume; LVID, left ventricle 
internal diameter; ntCVC, nontunneled central venous catheter; PVA, 
permanent vascular access; RCAVF, radiocephalic arteriovenous fistula; 
tcCVC, tunneled cuffed central venous catheter.
Overall (score) χ2 = 26.65, P = .009.
F I G U R E  1   Curves respectively illustrating the cumulative 
functional survival (equal to primary patency) of RCAVF over 
time in groups according to the value of LVEDV. LVEDV, left 
ventricle end-diastolic volume [Color figure can be viewed at 
wileyonlinelibrary.com]
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our subjects had very few cardiovascular disorders (Table 1) and EF 
≥50%, as inferior AVF blood flow was observed in patients with ab-
normal EF.22
The main reason for RCAVF dysfunction in the study was AVF 
stenosis (95%). However, only 15 (35.7%) patients received endo-
vascular or surgical interventions. Most of the others missed the 
opportunity for early treatment, which led to an abandonment rate 
of 41.5% during the study period. Generally, delayed detection and 
referral made it difficult to rescue the dysfunctional AVFs.
4.3 | Limitations
The present study had some limitations. Firstly, there was a small sam-
ple size and some inherent bias in its retrospective nature, which means 
we could not rule out selective bias of patients or acquire the entirety of 
relevant events or precise information such as medication, dialysis pre-
scription, and nutrition status during the study period. Although patients 
in this study visited our clinic regularly and underwent each operation in 
the same surgical team, they did not receive dialysis treatments in the 
same HD center. Additionally, we lacked echocardiographic data for the 
endpoint to further verify the association between the changes of car-
diovascular system and the function of AVF. Secondly, the deviation from 
the baseline data might weaken the reliability of the study. The echocardi-
ography was performed using the same machine in our hospital by skilled 
specialists, not the same technician. Lastly, the study population consisting 
of Chinese individuals did not reflect a multiethnic cohort. Hence, the re-
sults cannot be generalized to other ethnic groups or a general population.
Variable (per 1 unit increased) 
or (yes vs no) HR (a) 95%CI P HR (b) 95%CI P
Male 0.48 0.19-1.21 .12 0.61 0.26-1.42 .25
Age (year) 1.04 0.94-1.16 .48 1.06 0.95-1.17 .29
Diabetes mellitus 0.99 0.44-2.21 .98 1.2 0.55-2.63 .65
DBP (mm Hg) 0.98 0.93-1.03 .37 0.98 0.94-1.03 .48
LVID (mm) 1.05 0.89-1.23 .57 1.07 0.92-1.26 .39
MPAID (per 1 mm increased or 
≤21.5 mm)
0.68 0.55-0.83 <.001 4.3 1.89-9.8 .001
LVEDV (mL) 0.99 0.97-1.02 .55 0.98 0.96-1.01 .14
Previous No. of PVA 3.52 0.48-25.82 .22 5.61 0.64-49.26 .12
Previous functional length of 
AVFs (mo)
0.91 0.80-1.02 .12 0.89 0.78-1.01 .07
Previous functional length of 
tcCVCs (mo)
0.81 0.62-1.07 .14 0.82 0.63-1.09 .17
Previous duration of FV-
ntCVC (mo)
1.27 0.96-1.66 .09 1.19 0.91-1.56 .2
Previous duration of IVJ-
ntCVC (mo)
1.02 0.78-1.34 .89 0.96 0.72-1.27 .75
Right RCAVF 3.23 1.09-9.55 .034 2.95 1.02-8.54 .047
Abbreviations: DBP, diastolic blood pressure; FV, femoral vein; HR, Hazard rate; CI, confidence 
interval; IJV, internal jugular vein; LVEDV, left ventricle end-diastolic volume; LVID, left ventricle 
internal diameter; MPAID, main pulmonary artery internal diameter; ntCVC, nontunneled central 
venous catheter; PVA, permanent vascular access; RCAVF, radiocephalic arteriovenous fistula; 
tcCVC, tunneled cuffed central venous catheter.
model a (MPA as continuous variable): Overall (score) χ2 = 35.16, P = .001.
model b (added MPA ≤21.5 mm): Overall (score) χ2 = 37.13, p < .001.
TA B L E  4   Cox proportional 
hazard regression models for RCAVF 
abandonment
F I G U R E  2   Curves respectively illustrating the cumulative 
survival of RCAVF (equal to cumulative patency) during study 
period in groups according to the value of MPAID. MPAID, main 
pulmonary artery internal diameter [Color figure can be viewed at 
wileyonlinelibrary.com]
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5  | CONCLUSIONS
In the retrospective study of 82 elderly Chinese patients with 
RCAVF on HD, LVEDV, and MPAID assessed by echocardiogra-
phy showed significant predictive performance for the dysfunc-
tion and abandonment of RCAVF respectively, after adjustment 
for modality and duration of VA prior to RCAVF creation. The 
right side of RCAVF was also a risk factor both for dysfunction 
and abandonment. Significant differences existing between the 
Chinese population and others with respect to the patency of AVF 
necessitate additional studies.
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